The NF-κB pathway is a classical pathway regulating inflammation, and the activation of NF-κB has been confirmed in various cell types from COVID-19 patients [29] or post-stimulation with S protein [30] and its subunit S1 [31]. The gene discussed is NFKB1; the disease is COVID-19.